Q1 EARNINGS: J&J's pharma sales overtake devices
This article was originally published in Clinica
Executive Summary
Johnson & Johnson’s medical devices and diagnostics (MD&D) division was once again a weak spot, with first-quarter sales flat at $7.1bn.